Fundz

Iso Thrive Inc. reported raising $5.2 Million in an initial SEC Form D filing, from an offering of $6 Million

PRIVATEFeb 05, 2021$5.2M of $6M raised

Amount Raised

$5.2 Million

$5.2 Million sold, per SEC Form D (first sale Feb 5, 2021)

Round Type

Venture

HealdsburgBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Quick answer

ISOThrive raised $5.2 Million in a funding round, dated February 5, 2021. ISOThrive is based in Healdsburg, California, United States.

How much did ISOThrive raise?
ISOThrive raised $5.2 Million in a funding round on February 5, 2021.
What does ISOThrive do?
ISOThrive Inc. is a clinical-stage biopharmaceutical company that is developing novel, microbiome-targeted therapeutics for gastrointestinal diseases.
Where is ISOThrive based and how big is it?
ISOThrive is based in Healdsburg, California, United States.
Who are the decision-makers at ISOThrive?
Fundz holds 1 contact at ISOThrive. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as ISOThrive that raised within 45 days of this round, from Fundz verified event records.

  • Parabilis Medicines raised $23M on January 5, 2021.
  • OnKure Therapeutics raised $29M on March 5, 2021.
  • Oragenics raised $21M (Series C) on February 12, 2021.
  • Day One Biopharmaceuticals raised $130M (Series B) on February 10, 2021.
  • Citius Pharmaceuticals, Inc. raised $20M on February 1, 2021.
  • Zevra Therapeutics, Inc. raised $31M on January 13, 2021.

Who to call at ISOThrive, and when

A new round usually means ISOThrive is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ISOThrive raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ISOThrive, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ISOThrive. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ISOThrive

Location

Healdsburg, California, United States

About

ISOThrive Inc. is a clinical-stage biopharmaceutical company that is developing novel, microbiome-targeted therapeutics for gastrointestinal diseases. Its lead product, ISOT-101, is a first-in-class treatment being evaluated for Non-Erosive Reflux Disease (NERD). The company focuses on addressing significant unmet medical needs in this area.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ISOThrive raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts8 people are listed at ISOThrive. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ISOThrive's next move

See what Strategic adds

ISOThrive raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.